Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Micrus Endovascular has received Shonin approval from the Ministry of Health, Labour and Welfare to market its Cerecyte microcoil product line in Japan.
Subscribe to our email newsletter
The Cerecyte product line includes the MicruSphere, Presidio, HeliPaq and UltiPaq Cerecyte embolic coils, for the endovascular treatment of cerebral aneurysms.
Sales of the company’s Cerecyte microcoils will be managed by Goodman, Micrus Endovascular’s exclusive distributor in the Japanese market.
John Kilcoyne, chairman and CEO of Micrus Endovascular, said: “The approval of our Cerecyte line of microcoils represents a major opportunity for Micrus. We can now provide the Japanese neurointerventionalists with a full line of both platinum and Cerecyte coils for the treatment of cerebral aneurysms.”